Vaccine Adjuvants: New ways to evaluate their safety and effectiveness.
Presented by: Hana Golding, PhD;
Chief, FDA Laboratory of Retrovirus Research
FDA Center for Biologics Evaluation and Research
WHEN: Thursday, March 30, 2017
TIME: 12:00 – 1:00 pm, EST
Register HERE